Dr. Jewett's review examines how MDSCs inhibit NK cell anti-tumor activity through peptidases, highlighting therapeutic potential of peptidase inhibitors to enhance immune responses.
Free until March 15: dl.begellhouse.com/journals/2ff...
#MDSCs #Immunotherapy
TuHURA Biosciences CEO Dr. James Bianco explains the mechanism of action for the Delta Opioid Receptor which modifies the tumor microenvironment rather than targeting the tumor itself.
$HURA
#ImmunoOncology #CancerResearch #CancerImmunotherapy #ImmuneSuppression #MDSCs
youtu.be/8xSUa9LjsNk
TuHURA CEO Dr James Bianco explains how the delta opioid receptor (DOR) works and the way in which it affects immune system response
$HURA
#MDSCs #ImmunoOncology #CancerResearch #CancerTreatment #Oncology
youtube.com/shorts/eE8x8...
Dr Bianco introduces TuHURA’s Immune Modulating ADCs which link a VISTA inhibitor to a delta opioid receptor inhibitor to target the tumor microenvironment rather than the tumor itself
$HURA
#TumorMicroenvironment #ImmunoOncology #MDSCs #MyeloidCells #VISTA #Oncology #ADC youtube.com/shorts/jfTnJ...
#Research
Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer doi.org/10.1186/s435...
#TNBC #TTNinactivation #MDSCs #GlycolyticMetabolism #DLL4_MCT4
What is the role of #MDSCs in the female genital tract during inflammation?
Read all about it in our new publication in @mucosalimmunol.bsky.social
www.sciencedirect.com/science/arti...
Thanks to our team @vhir.bsky.social led by @txellgenesca.bsky.social
#Womenshealth #MucosalImmunology #STI
TuHURA Biosciences Presents Groundbreaking Research on Delta Opioid Receptor and Cancer Immunotherapy #USA #Tampa #TuHURA_Biosciences #Delta_Opioid_Receptor #MDSCs
Congrats @el_deusu @HortovaMarcela @MartinHelan and team for @CSAC_CZ prize for 2nd best paper in clinical and applied cytometry in 2021. @FNUSA_ICRC #CTM @UHKT_cz #sepsis #MDSCs #FlowCytometry #metaclustering